DrFirst, a Rockville, Md.-based health technology company, raised $50m in equity funding.
Sixth Street Growth made the investment. Following Sixth Street’s previous $35m investment and another $50m from Goldman Sachs Growth, both in 2020, DrFirst’s investment total over the past year is now $135m. In conjuntion with the funding, Lee Mooney of Sixth Street has joined DrFirst’s Board of Directors.
The company intends to use the funds to continue to expand operations and its business reach.
Led by James F. Chen, CEO and chairman, DrFirst makes e-prescription and telehealth-related software products for healthcare providers, payers and life science companies including medication management, care collaboration, medication adherence, and price transparency for prescriptions and medical procedures. The company’s solutions are used by nearly 300,000 healthcare professionals, including more than 100,000 prescribers, nearly half of the electronic health record (EHR) systems in the U.S., and more than 1,400 hospitals in the U.S. and Canada.
FinSMEs
14/05/2021